This message was sent to ##Email##
|
|
|
|
|
| |
HealthDay News via U.S. News & World Report
When you consider that a hot fudge sundae can top 500 calories, 30 minutes of walking at a slow pace will barely make a dent in undoing the damage.
But exercise does make a difference where it counts — for both weight loss and weight-loss maintenance as well as for overall health. The math is simple: Burn more calories than you take in and you'll lose weight.
READ MORE
Outside Magazine
Have you ever met anyone who regretted taking a good, hard day hike? Me neither.
There’s something special about moderately paced movement through nature that leaves one feeling refreshed, renewed and satisfied. Because of that, hiking is rarely considered a sport in the same way as trail running or mountain biking, both of which are more acutely painful and taxing on the body.
READ MORE
Men's Journal
Sales of fitness trackers have never been stronger. And that’s a bad thing, says Andy Galpin, a professor of kinesiology at the Center for Sport Performance at California State University. In fact, in his new book, "Unplugged: Evolve From Technology to Upgrade Your Fitness, Performance and Consciousness," Galpin and co-authors Brian MacKenzie and Phil White explain that the smarter path to fitness is to tap into the technology you’ve always had: your brain.
READ MORE
By Seth Sandronsky
 Just under 31 million U.S. youth, ages 6-14, take part in sports. Each year, injuries linked to sports and recreation send more than 2.6 million children to emergency departments, according to the Centers for Disease Control and Prevention. What can coaches, schools and recreation organizations do to reduce these injuries? We turn to the National Athletic Trainers' Association and their recently published guidelines.
READ MORE
The New York Times via The Boston Globe
Aerobic fitness seems to alter the interior workings of cells in ways that may substantially lower the risk of breast cancer.
A new study with female rats found that those that were the most fit were much less likely than other animals to develop cancer after exposure to a known carcinogen, even if they did not exercise.
The findings offer tantalizing new clues into the relationship between fitness, exercise and malignancies.
READ MORE
NBC News
Fasting may seem like a drastic way to lose weight, but it can be safe and effective when done in moderation, according to self-improvement blogger Dave Wentworth.
The mechanical engineer, who lives in Michigan, decided to try the 5:2 intermittent fasting diet after joining a weight-loss competition at his job in 2011. Simply put, the diet required him to eat normally five days a week and fast for two.
READ MORE
Outside Magazine
Fat has a complicated past. It went from being viewed as the fast track to weight gain to a surefire way for endurance athletes to teach their body to burn slower for longer. We looked at some of the most common misconceptions ideas behind the macronutrient — 1 of 3 nutritional components (fat, protein, and carbohydrates) required by humans to function — and stacked them up against the latest peer-reviewed literature and advice from the experts. Here’s what we found.
READ MORE
Women's Health Magazine
Whether you're trying to reduce your cancer risk, slash your carbon footprint, or you just want to take a stand as an animal lover, there are tons of benefits associated with going vegetarian. And one of those benefits could be weight loss. In fact, a study published in the American Journal of Clinical Nutrition concluded that people who ate about 250 grams of meat a day — roughly the size of one half-pound steak, piece of poultry, or processed meat — packed on more pounds over the course of five years compared to other study participants who ate less animal protein.
READ MORE
Forbes
If you’re reading this, you’ve probably heard someone say “you are what you eat” at some point in your life. And while there’s definitely some truth to this statement — age-old aphorisms don’t become age-old aphorisms for nothing — what many of us might not have considered is just how deeply its logic applies to some of the more important individual aspects of everyday life.
READ MORE
News-Medical.net
Adding 48 minutes of moderate exercise per week is associated with improvements in overall physical functioning and decreases in risks of immobility in older adults who are sedentary, finds a new study led by researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University.
READ MORE
Los Angeles Times
You can spend a lot of accumulated time on your bottom in the course of a day. Or you can sit for lengthy spells without a break.
Both, it turns out, are very bad for you.
Whether you’re a heavy sitter or a binge-sitter, racking up prolonged sedentary time increases your risk of early death, according to a study published in the Annals of Internal Medicine.
READ MORE
| | VITAMINS & PHARMACEUTICALS |
Business Insider
Supplements send about 23,000 people to the emergency room every year.
Because of the way the U.S. Food and Drug administration defines them, however, supplements are not regulated as drugs. It is only when a specific supplement is shown to cause significant harm that it is called out as unsafe.
READ MORE
| |
MISSED AN ISSUE OF ENEWS ON PREVENTION, WELLNESS & LIFESTYLE? VISIT AND SEARCH THE ARCHIVE TODAY. |
Bicycling
Forty percent of Americans pop at least one vitamin and mineral supplement every day. Healthy, active folks take even more, seemingly because they’re interested in staying healthy and active. But if you haven’t already, it’s time to reexamine your relationship with vitamins and mineral supplements. Mounting research has shown that in many cases, they not only fail to improve performance, but they may actually hinder it.
READ MORE
Men's Health via Fox News
If you think popping a handful of vitamins each day is the key to staying healthy, well, you might be doing it wrong.
In fact, your supplements might actually be putting your health at risk: Taking high doses of vitamin B6 and B12 supplements may increase your risk of lung cancer, especially if you smoke or have smoked in the past, a new study in the Journal for Clinical Oncology suggests.
READ MORE
|
| Jazz Pharmaceuticals is proud to announce that VYXEOS has been approved by the US Food and Drug Administration (FDA) for the treatment of adults with therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC). Please click here for more information. |
| Puma Biotechnology, Inc. today announced that the U.S. FDA has approved NERLYNX™ (neratinib), a once-daily oral tyrosine kinase inhibitor for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer, following adjuvant trastuzumab-based therapy. Please click here for more details and the full press release. |
| Seattle Genetics and Takeda Announce Positive Results from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma. The companies announced that the phase 3 ECHELON-1 clinical trial met its primary endpoint of a statistically significant improvement in modified progression-free survival (PFS) versus the control arm. Click here to view the full press release. |
| Join Zitter Health Insights’ (ZHI) research panel and earn honoraria - paid directly to you or to your favorite charity. ZHI provides innovative insights that help optimize patient access to pharmaceuticals. We work for and with life science companies, specialty pharmacies and managed healthcare organizations across the US. For nearly 30 years, our syndicated research and expertise have helped customers solve market access challenges. This research helps IDNs exercise greater influence over how the pharmaceutical industry approaches and interacts with them. We are recruiting IDN executives to participate in our research and your knowledge is paramount to providing key stakeholders with insights into the challenging issues involved with pharmaceutical access. We look forward to your participation in this important dialogue. Yes, I’d like to learn more and participate! |
| CVS Health today announced the company will launch Reduced Rx™, a prescription savings program that will offer discounts on certain medications – through CVS Health’s pharmacy benefits manager, CVS Caremark – directly to patients. The program will help patients with high out of pocket costs afford essential medications. Novo Nordisk will participate in the prescription savings program. Through this program, CVS Health and Novo Nordisk will offer Novolin R®, Novolin N® and Novolin 70/30® human insulin at a cost of $25 per 10ml vial, which reflects a potential savings of as much as $100 for cash paying patients. Click here for more information. |
| Intarcia Therapeutics, Inc. is a rapidly emerging biopharmaceutical company committed to developing innovative therapies utilizing the Medici Drug Delivery System™ – therapies that have the potential to transform the prevention and management of serious chronic diseases. Across chronic diseases, medication non-adherence can compromise clinical outcomes and drive excess cost to the healthcare system. Intarcia is working to address this problem through innovative technologies. We invite you to visit our website to learn more. |
| The National Institute for Health and Care Excellence (NICE) issued positive guidance recommending the use of the HeartFlow FFRct Analysis to help determine the cause of stable chest pain in patients. The HeartFlow FFRct Analysis is the first non-invasive technology to provide insight into both the extent of coronary artery disease and the impact that disease has on blood flow to the heart, aiding clinicians in selecting an appropriate treatment. Please click here to view the full press release. |
| Last month, Novo Nordisk received approval from the US Food and Drug Administration for the New Drug Application (NDA) for Xultophy® 100/3.6. Xultophy® 100/3.6 is a combination of insulin degludec and liraglutide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin or liraglutide. The FDA has required Novo Nordisk to distribute the safety notice as part of the Xultophy® 100/3.6 REMS program. Click Here for the Letter. Click Here for the fact sheet. |
| Courtagen Life Sciences, Inc., an innovative molecular information company focused on providing genetic diagnoses for neurological conditions through next generation sequencing, offers a broad range of genetic testing panels for epilepsy, including recently-added epiSEEK® Spotlight Panels designed to target genes that have been reported in association with specific phenotypes for epilepsy and seizure disorders. Please click here for more information. |
| New iOn PROGRESS™ Remote Therapy Monitoring system from Acelity marks first continuous monitoring and ready intervention for patients receiving negative pressure wound therapy at home, and supports patient compliance. Non-compliance can lead to unnecessary spending for excessive hospital readmissions ,and unnecessary ER visits. Please click here to review the full press release. |
| Based on published clinical data, Humana, Medical Mutual of Ohio and Preferred One independently determined and published policies stating that Biodesix’ VeriStrat® test can be considered medically necessary for patients with advanced NSCLC. The VeriStrat test provides physicians with prognostic and predictive information to inform treatment of advanced NSCLC, and can facilitate patient-physician conversations about prognosis, life expectancy, and treatment recommendations. Click here for more information. |
Check out JMCM’s new website at www.jmcmpub.org
|
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
